Release date: 7 February 2007
Promoter – Financial Intermediary
The promoter is a leading international company headquartered in Belgium and specialised in chemicals, plastics and pharmaceuticals.Location
Description
The project encompasses the promoter’s R&D related activities and investments in the pharmaceuticals sector over a period of up to 3 years.
Objectives
The project will support the promoter’s activities aiming at bringing a number of promising medicinal products currently in its pipeline through the pre-clinical and clinical development phases. As such the project will underpin the diversification of the promoter’s business.
Comments
Manufacture of basic pharmaceutical products.
Sector(s)
Proposed EIB finance (Approximate amount)
EUR 400 million.
Total cost (Approximate amount)
EUR 1000 million.
Environmental aspects
R&D activities will be carried out in the existing facilities, making use of the existing laboratories and pilot plants and an EIA, therefore, is not explicitly required by EU Directive 97/11. The environmental procedures of the promoter will be assessed during appraisal.
Procurement
The promoter is a private company not operating in the utilities sector and is thus not covered by EU Directives on procurement. The appraisal will confirm if the procedure is in the best interest of the project and satisfies the EIB’s procurement policy in terms of non-discrimination of suppliers and promotion of international competition.
Status
Signed - 22/07/2008
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).